|
|
Article: Helix BioMedix Completes Clinical Studies of SmartPeptides™ Products.(Clinical report)
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, announced the completion of a series of three clinical studies investigating the safety and efficacy of a serum, eye cream and moisturizer, each containing the Company's SmartPeptides™ technology, including the newly developed Heptapeptide-7. These studies demonstrate improvement in skin texture and appearance as well as the decrease in fine lines and wrinkles with Striking™ Skin Care formulations (see also Helix BioMedix, Inc.).
"Our SmartPeptides technology found in Striking Skin Care products performed well in clinical evaluation with high consumer appeal," said Dr. Tim Falla, ...